Free Trial

GlycoMimetics (GLYC) SEC Filings & 10K Form

GlycoMimetics logo
$0.22 -0.01 (-2.55%)
As of 04:00 PM Eastern

Recent GlycoMimetics SEC Filings

DateFilerForm TypeView
04/04/2025
12:29 PM
GlycoMimetics (Filer)
Form S-4/A
04/03/2025
6:30 AM
GlycoMimetics (Subject)
Form 425
04/03/2025
6:30 AM
GlycoMimetics (Subject)
Form 425
02/28/2025
4:05 PM
GlycoMimetics (Subject)
Form 425
02/27/2025
5:01 AM
GlycoMimetics (Subject)
Form 425
02/14/2025
5:38 PM
GlycoMimetics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
01/31/2025
4:00 PM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
8:00 AM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
8:00 AM
GlycoMimetics (Filer)
Form DEFA14A
12/26/2024
3:30 PM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
1:22 PM
GlycoMimetics (Subject)
Logos Global Management LP (Filed by)
Form SC 13G
11/13/2024
3:30 PM
GlycoMimetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
3:42 PM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
3:47 PM
GlycoMimetics (Filer)
Form DEFA14A
11/06/2024
4:41 PM
GlycoMimetics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
11/04/2024
1:01 PM
GlycoMimetics (Subject)
Weinstein Benjamin (Filed by)
Form SCHEDULE 13G/A
10/29/2024
7:09 AM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:09 AM
GlycoMimetics (Filer)
Form DEFA14A
08/15/2024
4:01 PM
GlycoMimetics (Subject)
Invus Global Management, LLC (Filed by)
Form SC 13G/A
08/09/2024
3:30 PM
DEBBANE RAYMOND (Reporting)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:30 PM
DEBBANE RAYMOND (Reporting)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
4:16 PM
DEBBANE RAYMOND (Reporting)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Siren, L.L.C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
2:55 PM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
6:24 PM
GlycoMimetics (Subject)
Invus Global Management, LLC (Filed by)
Form SC 13G/A
07/29/2024
4:55 PM
DEBBANE RAYMOND (Reporting)
GlycoMimetics (Issuer)
Invus Global Management, LLC (Reporting)
Siren, L.L.C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2024
3:29 PM
GlycoMimetics (Issuer)
Rock Edwin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:15 PM
GlycoMimetics (Issuer)
Hahn Brian M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
8:30 AM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
7:30 AM
GlycoMimetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:30 PM
GlycoMimetics (Issuer)
Koenig Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:GLYC) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners